Automate Your Wheel Strategy on ELV
With Tiblio's Option Bot, you can configure your own wheel strategy including ELV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ELV
- Rev/Share 862.7989
- Book/Share 195.2259
- PB 1.7502
- Debt/Equity 0.0211
- CurrentRatio 1.5602
- ROIC 0.0701
- MktCap 75714524166.0
- FreeCF/Share 16.6829
- PFCF 20.0994
- PE 13.9035
- Debt/Assets 0.0076
- DivYield 0.0201
- ROE 0.1291
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ELV | Deutsche Bank | Buy | Hold | -- | $320 | Dec. 19, 2025 |
| Initiation | ELV | Goldman | -- | Neutral | -- | -- | Oct. 14, 2025 |
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | July 21, 2025 |
| Downgrade | ELV | Leerink Partners | Outperform | Market Perform | -- | $310 | July 18, 2025 |
| Downgrade | ELV | Robert W. Baird | Outperform | Neutral | -- | $529 | April 15, 2025 |
| Upgrade | ELV | Argus | Hold | Buy | -- | $450 | March 17, 2025 |
| Downgrade | ELV | Stephens | Overweight | Equal Weight | $520 | $440 | Jan. 22, 2025 |
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
Elevance Health Reflects On The Changed Role of Health Plans
Published: December 12, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--As 2025 draws to a close, Elevance Health highlights how today's health plans are evolving to better support their members in a broader range of situations that affect health, including cancer diagnoses, mental health crises, and unexpected health concerns during pregnancy. From employer-sponsored health insurance to government-sponsored programs, health plans are evolving to better support their members in a broader range of situations that affect health. In part.
Read More
Impax U.S. Sustainable Economy Fund Q3 2025 Contributors And Detractors
Published: December 08, 2025 by: Seeking Alpha
Sentiment: Positive
Intel (INTC) rallied strongly in September as the company announced a partnership with Nvidia on integrating Intel's x86 central processing units (CPUs) with Nvidia GPUs in AI server systems. Oracle (ORCL) (Information Technology, Systems Software) performed strongly on the continued follow-through following strong quarterly results. Elevance Health (ELV) (Health Care, Managed Health Care) has a high Corporate Resilience Score and is aligned to the Health Access and Innovation theme.
Read More
Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence
Published: December 05, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health announced today that it expanded access of its Virtual Assistant, a digital experience designed to help members easily access information, understand their benefits, and find care with confidence. Available through the Sydney Health app and Elevance Health–affiliated health plan websites, Virtual Assistant uses conversational technology to simplify healthcare navigation and improve engagement between members and their health plans. “At Elevance Hea.
Read More
How Elevance Health is Evolving the Healthcare Consumer Experience Through Improved Personalization and Higher Touch Service
Published: November 24, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is making healthcare more intuitive and personalized by using technology to simplify access and build trust among health plan members.
Read More
Columbia Contrarian Core Fund Q3 2025 Performance Review
Published: November 18, 2025 by: Seeking Alpha
Sentiment: Negative
The fund underperformed its benchmark, the Russell 1000 Index, during the third quarter. Videogame producer Electronic Art's was the top contributor during the period. Elevance Health was the top underperformer over the period.
Read More
Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings
Published: November 07, 2025 by: MarketBeat
Sentiment: Positive
If you're a parent, you've likely battled with your children over different options at dinner time. What kid wouldn't love to eat hot dogs for dinner every night and then wash it down with a milkshake?
Read More
Elevance Health's Profits Eclipse $1.1 Billion Despite Rising Costs
Published: October 21, 2025 by: Forbes
Sentiment: Positive
Elevance Health Tuesday said third quarter net income rose to nearly $1.2 billion despite rising costs in its government subsidized health insurance plans.
Read More
Elevance Health (ELV) Tops Q3 Earnings and Revenue Estimates
Published: October 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health (ELV) came out with quarterly earnings of $6.03 per share, beating the Zacks Consensus Estimate of $4.98 per share. This compares to earnings of $8.37 per share a year ago.
Read More
Elevance beats quarterly profit estimates as medical costs remained in check
Published: October 21, 2025 by: Reuters
Sentiment: Positive
Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check.
Read More
Elevance Health Reports Third Quarter 2025 Results
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results. "Our third quarter results were in line with expectations and reflect disciplined execution across Elevance Health. In a dynamic healthcare environment, we're focused on advancing affordability and elevating the member experience through our growing value-based care partnerships and AI-enabled digital solutions that simplify access and improve outcomes. As we plan for 2026, we remain discipline.
Read More
Wall Street's Insights Into Key Metrics Ahead of Elevance Health (ELV) Q3 Earnings
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Read More
Will Rising Costs Hurt Elevance's Q3 Earnings Despite Higher Premiums?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Negative
ELV's third-quarter earnings may face pressure as rising costs and weaker Medicaid memberships offset premium gains.
Read More
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Negative
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit
Published: October 14, 2025 by: PRNewsWire
Sentiment: Neutral
SAN DIEGO , Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV) shares. Investors who purchased shares of Elevance Health, Inc. (NYSE: ELV) prior to April 2024 and continue to hold any of those NYSE: ELV shares have also certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
Published: September 12, 2025 by: Zacks Investment Research
Sentiment: Positive
ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.
Read More
Is ELV's Push Beyond Insurance a Blueprint for the Healthcare Future?
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health expands beyond insurance into primary care, digital health and pharmacy services, aiming to reshape healthcare delivery.
Read More
CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.
Read More
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.
Read More
Elevance Health - Piggy Bank Or Headache?
Published: August 21, 2025 by: Seeking Alpha
Sentiment: Neutral
Elevance and peers face earnings pressure from rising medical costs, driven by deferred care, expensive drugs, and persistent medical inflation. The segment has re-rated, and now offers good value. Investor sentiment has returned, and capital is rotating into healthcare.
Read More
UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Neutral
UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.
Read More
Elevance Shoots for the Stars But Lands at 3.5: $375M Bonus Gone?
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Federal judge dismisses ELV's lawsuit challenging Medicare Advantage star ratings, leading to a $375M bonus loss tied to its star score.
Read More
Food as Medicine: Elevance Health & NACHC Integrate Nutrition in Care
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Neutral
ELV partners with NACHC to bring Food as Medicine into primary care, targeting nutritional insecurities and chronic disease.
Read More
When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Positive
ELV trims 2025 outlook as medical costs climb, but commercial growth and Carelon's momentum aim to steady performance.
Read More
When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD Decline
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Negative
ELV's 20% YTD slump reflects shrinking memberships, rising costs and deepening analyst pessimism despite long-term growth levers.
Read More
3 Stocks That Could Double Before 2027
Published: August 11, 2025 by: 24/7 Wall Street
Sentiment: Positive
These stocks have high upside potential through 2027. They're sitting at solid discounts and have good fundamentals.
Read More
Elevance Health: CEO Buys As CareBridge Drives Strong Growth
Published: July 24, 2025 by: Seeking Alpha
Sentiment: Positive
On July 18, the CEO bought $2.4MM worth, after the sell-off following the last earnings call. Carelon Services is growing fast, supported by the December acquisition of CareBridge. The aging population, the rising interest in well-being, and the potential expansion in Florida and Texas are a ray of light in the current gloomy context of the company.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More
Published: July 17, 2025 by: Investopedia
Sentiment: Positive
Major U.S. equities indexes were higher at midday Thursday in the wake of better-than-expected quarterly results from several major companies. The Dow, S&P 500, and Nasdaq all advanced.
Read More
Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs
Published: July 17, 2025 by: Zacks Investment Research
Sentiment: Negative
ELV's Q2 EPS slides 12.6% y/y and misses estimates as rising Medicaid and ACA costs weigh on the results.
Read More
Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript
Published: July 17, 2025 by: Seeking Alpha
Sentiment: Neutral
Elevance Health, Inc. (NYSE:ELV ) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Koziara Boudreaux - President, CEO & Director Mark Bradley Kaye - Executive VP & CFO Morgan Kendrick - Corporate Participant Nathan Allen Rich - Vice President of Investor Relations Peter David Haytaian - Executive VP and President of Carelon & CarelonRx Conference Call Participants Albert J. William Rice - UBS Investment Bank, Research Division Andrew Mok - Barclays Bank PLC, Research Division Ann Kathleen Hynes - Mizuho Securities USA …
Read More
About Elevance Health Inc. (ELV)
- IPO Date 2001-10-30
- Website https://www.elevancehealth.com
- Industry Medical - Healthcare Plans
- CEO Gail Koziara Boudreaux
- Employees 104200